Adherence
Replacing 30 minutes of sedentary time with moderate-to-vigorous physical activity (MVPA) significantly reduces cancer mortality risk by 31%, while replacing it with light-intensity physical activity (LIPA) reduces risk by 8%.
You don't need to run marathons to lower your cancer mortality risk. Simply swapping 30 minutes of sitting for 30 minutes of moderate exercise (like brisk walking) cuts your risk by 31%. Even swapping that time for light activity (like standing or slow walking) cuts risk by 8%. Prioritize breaking up sitting time with any form of movement.
Replacing 30 minutes of sedentary time with LIPA was significantly associated with an 8% (per 30 minutes: HR, 0.92; 95% CI, 0.86-0.97) lower risk of cancer mortality; MVPA was significantly associated with a 31% (per 30 minutes: HR, 0.69; 95% CI, 0.48-0.97) lower risk of cancer mortality.
Why this rating
Prospective cohort with objective measurement and robust statistical modeling (isotemporal substitution), though still observational.
Source
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults
Susan C. Gilchrist et al. · JAMA Oncology · 2020
DOI 10.1001/jamaoncol.2020.2045
More from this paper
- Higher total daily sedentary time is independently associated with increased cancer mortality risk in middle-aged and older adults, regardless of moderate-to-vigorous physical activity (MVPA) levels.Good
- The duration of uninterrupted sedentary bouts (prolonged sitting) is not significantly associated with cancer mortality risk after adjusting for MVPA and other covariates.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →